NY-LIME-TRADNG/TKEPROFIT
Lime Trading Corp (“Lime Trading”), a tech-first agency broker headquartered in New York City, proudly announces its strategic partnership with west coast start up TakeProfit, a pioneering community-driven trader platform based in San Francisco, California. This collaboration was born from a joint belief that traders should have access to the best tools and technology no matter their strategy. This new partnership offers retail traders access to the newest innovations in charting and technical analysis, coupled with Lime Trading's industry-leading trade execution.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240502144682/en/
The newly launched TakeProfit trading platform now offers widgets that integrate seamlessly with Lime Trading. Lime clients will be able to now place trades from the TakeProfit platform and view their portfolio all in one place. (Graphic: Business Wire)
Lime Trading is the only broker connected to TakeProfit, offering exclusive access to a trading widget native to the TakeProfit platform. Now traders can ideate and trade in one, seamless experience without ever leaving the platform. “We are thrilled to introduce this integration with TakeProfit,” remarked Johan Sandblom, CEO at Lime Trading. “By merging Lime Trading's expertise in trade execution with TakeProfit's innovative platform, we are equipping retail traders with the essential tools needed to help navigate today's dynamic markets efficiently.”
Alexey Shulzhenko, TakeProfit’s Founder & CEO said, “We partnered with Lime because they have a passion to build the best for traders, by traders. Their focus on providing all traders with lower latency technology aligns with our mission to bring traders the tools they need to trade more effectively.”
This partnership is just one of a few, recent product enhancements that Lime Trading has released to enhance their retail offering. Most recently they’ve added a Python SDK for their REST API and streamlined their demo paper trading access for traders to test drive Lime for themselves.
Traders wanting to try the TakeProfit trade integration that do not yet have a Lime account to experience this new integration, are able to sign up for a free demo paper account. For more information regarding Lime Trading and TakeProfit's new partnership, visit m.lime.co/takeprofit.
About Lime Trading
For over twenty years, Lime Trading has been focused on developing tools and technology to enhance traders’ access to markets. Focused on lower latency execution, Lime Trading works with retail and institutional clients alike to offer a broad range of APIs, platforms, and technology solutions to traders worldwide. Lime Trading Corp is an SEC-registered broker-dealer, member of FINRA/SIPC/NFA. For more information, visit Lime.co.
About TakeProfit
TakeProfit is a community-driven trading platform equipped with monetization tools for traders. It facilitates sharing research and making better trading decisions, allowing members to capitalize on their expertise. Workspaces are created using widgets, providing a customizable trading environment with immersive charting, custom indicators, screeners, financials, and other tools. TakeProfit brings desktop functionality to the web, utilizing new browser technologies and leveraging the advantages of cloud products. Learn more about TakeProfit at TakeProfit.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240502144682/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
ProAmpac Acquires International Paper’s Bag Converting Operations17.10.2025 16:09:00 CEST | Press release
ProAmpac, a global leader in flexible packaging and material science, has acquired the bag converting operations of International Paper (“IP”), a global leader in sustainable packaging. The acquisition expands ProAmpac’s converting capabilities, further advancing the company’s Fiberization of Packaging® strategy and enhancing its ability to deliver customized bag solutions for the grocery, convenience store, and quick-service restaurant markets. “Global demand for reliable, recyclable paper packaging continues to grow rapidly amid evolving consumer expectations and market trends redefining recyclability,” stated Greg Tucker, ProAmpac founder, vice chairman, and chief executive officer. “ProAmpac’s acquisition of IP’s bag operation supports our Fiberization of Packaging initiatives, helping us better serve customers by extending our expertise in material science to the US west coast with additional capabilities and redundancies,” continued Tucker. “IP’s bag business is strong, being bui
Pimicotinib Treatment Demonstrates Deep and Durable Tumor Responses and Continued Improvements in Pain and Function for Patients with TGCT17.10.2025 16:00:00 CEST | Press release
With median follow-up of 14.3 months, pimicotinib demonstrated increasing ORR over time, from 54% at Week 25 to 76.2%Global Phase 3 MANEUVER study demonstrated ongoing improvements in key secondary endpoints including pain and functionApplication for marketing authorization under review by China National Medical Products Administration (NMPA), with additional applications planned in the U.S. and other marketsNot intended for Canada-, UK- or US-based media Merck, a leading science and technology company, today announced the presentation of longer-term results from the global Phase 3 MANEUVER trial evaluating pimicotinib, an investigational colony stimulating factor-1 receptor (CSF-1R) inhibitor in development by Abbisko Therapeutics Co., Ltd., for the treatment of patients with tenosynovial giant cell tumor (TGCT). This latest analysis showed that, with a median follow-up of 14.3 months, the objective response rate (ORR) for people treated with pimicotinib from the beginning of the stud
Vertex Announces Progress in Povetacicept Development Program and Presentation of New Data at American Society of Nephrology Kidney Week17.10.2025 15:04:00 CEST | Press release
- Food and Drug Administration grants rolling review of Biologics License Application for povetacicept in IgA nephropathy; Vertex to submit first module before end of year - - Second pivotal development program of povetacicept underway with Phase 2b/3 trial initiation in primary membranous nephropathy - - Updated data from RUBY-3 trial of povetacicept accepted for late breaking oral presentation; inaxaplin study design and APOL1-mediated kidney disease related data accepted for poster presentation - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced several important updates across its development program for povetacicept (pove), an investigational recombinant fusion protein therapeutic and dual antagonist of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines. Pove has demonstrated best-in-class potential in IgA nephropathy (IgAN) and primary membranous nephropathy (pMN) and has pipeline-in-a-product potential across a range of B c
Qualcomm Announces Quarterly Cash Dividend17.10.2025 15:00:00 CEST | Press release
Qualcomm Incorporated (NASDAQ: QCOM) today announced a quarterly cash dividend of $0.89 per common share, payable on December 18, 2025, to stockholders of record at the close of business on December 4, 2025. About Qualcomm Qualcomm relentlessly innovates to deliver intelligent computing everywhere, helping the world tackle some of its most important challenges. Building on our 40 years of technology leadership in creating era-defining breakthroughs, we deliver a broad portfolio of solutions built with our leading-edge AI, high-performance, low-power computing, and unrivaled connectivity. Our Snapdragon® platforms power extraordinary consumer experiences, and our Qualcomm Dragonwing™ products empower businesses and industries to scale to new heights. Together with our ecosystem partners, we enable next-generation digital transformation to enrich lives, improve businesses, and advance societies. At Qualcomm, we are engineering human progress. Qualcomm Incorporated includes our licensing
Illumynt Reports Q3 2025 Business Update17.10.2025 14:39:00 CEST | Press release
Q3 2025 was a busy quarter once again for us here at illumynt. In addition to naming a new CEO, we executed on a number of initiatives that are propelling our organization forward. Revenue for the quarter exceeded $30 million- keeping us on track for our 2025 plan. More importantly we executed three different large-scale data center decommission projects with almost no material ending up as scrap. All of the AI-focused enterprise equipment and components recovered from the decommissions were resold at top market value. We head into Q4 with high expectations and our eyes wide open. We’re celebrating the 20-year anniversary of our facility in Hong Kong and looking to add another location in the region to help us process inbound AI data center equipment. Stay tuned for updates. There will be more on the way. View source version on businesswire.com: https://www.businesswire.com/news/home/20251017446548/en/
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom